EFFICACY AND SAFETY OF GASTRO-RESISTANT PHOSPHATIDYLCHOLINE (LT-02) FOR MAINTENANCE OF REMISSION IN PATIENTS WITH ULCERATIVE COLITIS INITIALLY REFRACTORY TO MESALAZINE: A RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY PLACEBO-CONTROLLED STUDY (PCG-4)

(1) Agaplesion Markus Krankenhaus,Frankfurt,Germany

(2) Universitätsklinik Heidelberg,Heidelberg,Germany

(3) O.O. Bogomolets National Medical University,Kiev,Ukraine

(4) Endoskopia Sp. z o.o.,Sopot,Poland

(5) Universitätsklinikum Schleswig-Holstein, Campus Lübeck,Luebeck,Germany

(6) Internistische Gemeinschaftspraxis,Ludwigshafen,Germany

(7) Praxis für Gastroenterologie,Berlin,Germany

(8) Asklepios West-Klinikum,Hamburg,Germany

(9) Interdisciplinary Crohn Colitis Centre Rhein-Main,Frankfurt,Germany

(10) Centrum Diagnostyczno-Lecznicze Barska,Wloclawek,Poland

(11) North-Western State Medical University named after I. I. Mechnikov,St. Petersburg,Russian Federation

(12) Technische Universitaet Muenchen, III. Medizinische Klinik,Munich,Germany

(13) Kliniken Essen-Mitte,Essen,Germany

(14) Gabinet Endoskopii Przewodu Pokarmowego,Krakow,Poland

(15) City Clinical Hospital No 6,Zaporyzhzya,Ukraine

(16) Dr. Falk Pharma GmbH,Freiburg,Germany

(17) Medizinische Universität Wien,Wien,Austria



This item was part of UEG Week 2018

This item can be cited as: United European Gastroenterology Journal 2018; 6 (Supplement 1)